C. Barnas

Benzodiazepines: Utilization and Patterns of Use in a University Hospital

W. Fleischhacker, C. Barnas, C. Stuppäck, 1989, Pharmacopsychiatry.

Investigation of Benzodiazepine-Consumers Concerning Intake-Habits,Signs of Abuse or Dependence, and Information About the Drug

W. Fleischhacker, H. Hinterhuber, C. Stuppäck, 1988, Pharmacopsychiatry.

The Effect of Orlistat on Plasma Levels of Psychotropic Drugs in Patients With Long-term Psychopharmacotherapy

E. Hilger, S. Quiner, I. Ginzel, 2002, Journal of clinical psychopharmacology.

Is schizophrenia linked to alteration in cellular immunity?

D. Fuchs, W. Fleischhacker, G. Reibnegger, 1989, Schizophrenia Research.

Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double‐blind trial vs. haloperidol

W. Fleischhacker, B. Sperner-Unterweger, C. Miller, 1992, International clinical psychopharmacology.

Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia

S. Kasper, K. Fuchs, W. Sieghart, 1998, Schizophrenia Research.

Assessment of the alcohol withdrawal syndrome--validity and reliability of the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A).

W. Fleischhacker, M. Hummer, H Oberbauer, 1994, Addiction.

Clozapine-induced transient white blood count disorders.

W. Fleischhacker, M. Hummer, A. Saria, 1994, The Journal of clinical psychiatry.